Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Also see the archival list of Science's Compass: Enhanced Perspectives
STEM CELLS: Enhanced: Setting Standards for Human Embryonic Stem Cells
Ali H. Brivanlou, Fred H. Gage, Rudolf Jaenisch, Thomas Jessell, Douglas Melton, Janet Rossant
Human embryonic stem cells (HESCs) have great potential in regenerative medicine and provide a window on early human embryonic development. In their Perspective, Brivanlou and colleagues review our current understanding of the cellular, molecular, and embryological properties of HESCs and suggest how standardized measures could be used to facilitate comparison across different human embryonic cell lines.
A. H. Brivanlou is at the Rockefeller University, New York, NY 10021, USA. E-mail: brvnlou{at}rockefeller.edu F. H. Gage is at the Salk Institute for Biological Sciences, San Diego, CA 92037, USA. R. Jaenisch is at the Whitehead Institute, Cambridge, MA 02142-1479, USA. T. Jessell is a Howard Hughes Medical Institute investigator at Columbia University, New York, NY 10032, USA. D. Melton is at Harvard University, Cambridge, MA 02138, USA. J. Rossant is at Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada.
CTG repeat instability in a human embryonic stem cell line carrying the myotonic dystrophy type 1 mutation.
N. De Temmerman, S. Seneca, A. Van Steirteghem, P. Haentjens, J. Van der Elst, I. Liebaers, and K.D. Sermon (2008)
Mol. Hum. Reprod.
14, 405-412
|Abstract »|Full Text »|PDF »
Asymmetric mitosis: Unequal segregation of proteins destined for degradation.
L. C. Fuentealba, E. Eivers, D. Geissert, V. Taelman, and E. M. De Robertis (2008)
PNAS
105, 7732-7737
|Abstract »|Full Text »|PDF »
The road to pluripotence: the research response to the embryonic stem cell debate.
Extensive contribution of embryonic stem cells to the development of an evolutionarily divergent host.
A. P. Xiang, F. F. Mao, W.-Q. Li, D. Park, B.-F. Ma, T. Wang, T. W. Vallender, E. J. Vallender, L. Zhang, J. Lee, et al. (2008)
Hum. Mol. Genet.
17, 27-37
|Abstract »|Full Text »|PDF »
Hematopoietic Development from Human Embryonic Stem Cells.
Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
J. D. Raman, N. P. Mongan, L. Liu, S. K. Tickoo, D. M. Nanus, D. S. Scherr, and L. J. Gudas (2006)
Carcinogenesis
27, 499-507
|Abstract »|Full Text »|PDF »
Down-Regulation of Stem Cell Genes, Including Those in a 200-kb Gene Cluster at 12p13.31, Is Associated with In vivo Differentiation of Human Male Germ Cell Tumors.
J. E. Korkola, J. Houldsworth, R. S.V. Chadalavada, A. B. Olshen, D. Dobrzynski, V. E. Reuter, G. J. Bosl, and R.S.K. Chaganti (2006)
Cancer Res.
66, 820-827
|Abstract »|Full Text »|PDF »
Temporal and parental-specific expression of imprinted genes in a newly derived Chinese human embryonic stem cell line and embryoid bodies.
B. W. Sun, A. C. Yang, Y. Feng, Y. J. Sun, Y. f. Zhu, Y. Zhang, H. Jiang, C. L. Li, F. R. Gao, Z. H. Zhang, et al. (2006)
Hum. Mol. Genet.
15, 65-75
|Abstract »|Full Text »|PDF »
Stem Cell Approaches for the Treatment of Renal Failure.
Nuclear Reprogramming of Somatic Cells After Fusion with Human Embryonic Stem Cells.
C. A. Cowan, J. Atienza, D. A. Melton, and K. Eggan (2005)
Science
309, 1369-1373
|Abstract »|Full Text »|PDF »
Patient-Specific Embryonic Stem Cells Derived from Human SCNT Blastocysts.
W. S. Hwang, S. I. Roh, B. C. Lee, S. K. Kang, D. K. Kwon, S. Kim, S. J. Kim, S. W. Park, H. S. Kwon, C. K. Lee, et al. (2005)
Science
308, 1777-1783
|Abstract »|Full Text »|PDF »
Human embryonic stem cells maintained in the absence of mouse embryonic fibroblasts or conditioned media are capable of hematopoietic development.
L. Wang, L. Li, P. Menendez, C. Cerdan, and M. Bhatia (2005)
Blood
105, 4598-4603
|Abstract »|Full Text »|PDF »
Embryonic Stem Cells: Prospects for Developmental Biology and Cell Therapy.
Progress with Nonhuman Primate Embryonic Stem Cells.
D. P. Wolf, H.-C. Kuo, K.-Y. F. Pau, and L. Lester (2004)
Biol Reprod
71, 1766-1771
|Abstract »|Full Text »|PDF »
Tissue Engineering, Stem Cells, and Cloning: Opportunities for Regenerative Medicine.
C. J. Koh and A. Atala (2004)
J. Am. Soc. Nephrol.
15, 1113-1125
|Full Text »|PDF »
Conversion of myoblasts to physiologically active neuronal phenotype.
Y. Watanabe, S. Kameoka, V. Gopalakrishnan, K. D. Aldape, Z. Z. Pan, F. F. Lang, and S. Majumder (2004)
Genes & Dev.
18, 889-900
|Abstract »|Full Text »|PDF »
New Human Embryonic Stem-Cell Lines -- More Is Better.
J. Gearhart (2004)
N. Engl. J. Med.
350, 1275-1276
|Full Text »|PDF »
Derivation of Embryonic Stem-Cell Lines from Human Blastocysts.
C. A. Cowan, I. Klimanskaya, J. McMahon, J. Atienza, J. Witmyer, J. P. Zucker, S. Wang, C. C. Morton, A. P. McMahon, D. Powers, et al. (2004)
N. Engl. J. Med.
350, 1353-1356
|Full Text »|PDF »
Unique gene expression signatures of independently-derived human embryonic stem cell lines.
M. J. Abeyta, A. T. Clark, R. T. Rodriguez, M. S. Bodnar, R. A. R. Pera, and M. T. Firpo (2004)
Hum. Mol. Genet.
13, 601-608
|Abstract »|Full Text »|PDF »